Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

WIERDA, WILLIAM G

One or more keywords matched the following items that are connected to WIERDA, WILLIAM G

Item Type	Name
Concept	Immunoglobulin Heavy Chains
Concept	Immunoglobulin Variable Region
Concept	Somatic Hypermutation, Immunoglobulin
Concept	Immunoglobulin D
Concept	Genes, Immunoglobulin
Concept	Immunoglobulin Light Chains
Concept	Genes, Immunoglobulin Heavy Chain
Concept	Immunoglobulin M
Academic Article	Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression.
Academic Article	High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia.
Academic Article	Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins.
Academic Article	Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology.
Academic Article	Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.
Academic Article	Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens.
Academic Article	Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia.
Academic Article	Array comparative genomic hybridization analysis identifies recurrent gain of chromosome 2p25.3 involving the ACP1 and MYCN genes in chronic lymphocytic leukemia.
Academic Article	Genetics and molecular biology of chronic lymphocytic leukemia.
Academic Article	p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy.
Academic Article	High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia.
Academic Article	Clinical characteristics, response to therapy, and survival of African American patients diagnosed with chronic lymphocytic leukemia: joint experience of the MD Anderson Cancer Center and Duke University Medical Center.
Academic Article	Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.
Academic Article	Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.
Academic Article	Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia.
Academic Article	Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia.
Academic Article	High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia.
Academic Article	?2 -microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemia.
Academic Article	Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia.
Academic Article	Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Academic Article	The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.
Academic Article	Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations.
Academic Article	RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences.

Search Criteria

Immunoglobulin A